Previous 10 | Next 10 |
Safe-T Group (NASDAQ: SFET ) +44% as its wholly owned subsidiary, NetNut has expanded into a new market with the signing of agreements with three leading companies operating in the consumer VPN sector. More news on: Safe-T Group Ltd, Surface Oncology, Inc., Cheetah Mobile Inc., St...
SOLANA BEACH, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the proprietary ...
Evoke Pharma (NASDAQ: EVOK ): Q1 GAAP EPS of -$0.07 misses by $0.02 . More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Gimoti™ Prescription Drug User Fee Act (PDUFA) date is June 19, 2020 SOLANA BEACH, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financi...
New York City, NY: March 25, 2020 - Published via (Wired Release) - Recent Research and Future Market Potential of Gastroparesis Drugs Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information...
Evoke Pharma (NASDAQ: EVOK ): FY GAAP EPS of -$0.32 misses by $0.01 . More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SOLANA BEACH, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2019. ...
SOLANA BEACH, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for...
Sarepta Therapeutics ( SRPT ) fell victim to the FDA's whims as the stock tumbled more than 3 percent following the issues raised by the FDA against its drug candidate Vyondys 53 (golodirsen). The drug was earlier rejected by the FDA last year. However, given what we can only call "popular p...
Thinly traded nano cap Evoke Pharma (NASDAQ: EVOK ) perks up 10% premarket on modestly higher volume on the heels of its agreement with life sciences commercial services provider Eversana for the commercialization and distribution of Gimoti (metoclopramide) nasal spray in the U...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK)...